(Q45201445)

10 December 2017

title

Successful oral valganciclovir treatment of cytomegalovirus infection during Campath-1H therapy (English)

1 reference

10 December 2017

0 references

1 reference

cytomegaloviral disease

1 reference

H González

1

1 reference

10 December 2017

J P Vernant

series ordinal

2

1 reference

10 December 2017

E Caumes

series ordinal

3

1 reference

10 December 2017

publication date

1 March 2005

1 reference

10 December 2017

1 reference

10 December 2017

volume

19

1 reference

10 December 2017

issue

3

1 reference

10 December 2017

page(s)

478

1 reference

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403636

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403636

Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403636

Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403636

Valganciclovir: A new oral alternative for cytomegalovirus retinitis in human immunodeficiency virus-seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403636

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403636

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403636

1 reference

Dimensions Publication ID

10 December 2017

1016458864

0 references

1 reference